 Philadelphia Inquirer (blog) | Teva's Cephalon recalls 1 lot of injectable leukemia drug Treanda Philadelphia Inquirer (blog) The drug is approved for the treatment of patients with "indolent B-cell non-Hodgkin's lymphoma (NHL) that has progressed during or within 6 months of treatment with rituximab-containing regimen." The lot recalled is packaged in 8 mL vials and was ... Cephalon, Inc. Issues Voluntary Nationwide Recall of Treanda |
